IP
JAZZ icon

Isthmus Partners’s Jazz Pharmaceuticals JAZZ Stock Holding History

Isthmus Partners’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$561K Buy
2,330
+160
+7% +$35.1K 0.05% 147
2026
Q1 		$410K Sell
2,170
-1,197
-36% -$209K 0.04% 149
2025
Q4 		$572K Sell
3,367
-55
-2% -$8.43K 0.06% 135
2025
Q3 		$451K Buy
3,422
+5
+0.1% +$600 0.1% 83
2025
Q2 		$363K Hold
3,417
– – 0.04% 166
2025
Q1 		$424K Buy
3,417
+58
+2% +$7.57K 0.05% 152
2024
Q4 		$414K Buy
3,359
+157
+5% +$18.5K 0.05% 153
2024
Q3 		$357K Buy
+3,202
New +$351K 0.04% 157

Other funds holding JAZZ

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
ACM
Argent Capital Management St Louis, Missouri $3.17B AUM 36.16% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
PL
Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
BCM
BTC Capital Management Des Moines, Iowa $1.65B AUM 27.85% 1-Year Est. Return
SOADOR
State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

Isthmus Partners's JAZZ Position: Q2 2026 in Review

Isthmus Partners increased its Jazz Pharmaceuticals (JAZZ) stake by 7.4% in Q2 2026, buying an estimated $35.1K and bringing the position to 2,330 shares worth $561K. The position accounts for 0.05% of the portfolio, ranked #147.

Isthmus Partners first reported a position in JAZZ in Q3 2024 and has held it in 8 quarters since. The position peaked at $572K in Q4 2025. 87 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Isthmus Partners held 2,330 shares of Jazz Pharmaceuticals worth $561K as of Q2 2026.
  • Isthmus Partners bought 160 Jazz Pharmaceuticals shares in Q2 2026, an estimated $35.1K.
  • Jazz Pharmaceuticals made up 0.05% of Isthmus Partners's portfolio in Q2 2026, its #147 holding.
  • Isthmus Partners first reported a position in Jazz Pharmaceuticals in Q3 2024 and has held it in 8 quarters since.
  • Isthmus Partners's Jazz Pharmaceuticals position peaked at $572K in Q4 2025.
  • 87 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Isthmus Partners's 13F filing for Q2 2026, filed 20 Jul 2026.